Intepirdine (RVT-101)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intepirdine (RVT-101), covering 2018-04-18 to 2018-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension [Phase 2, Phase 3]